E2F1 and hepatocellular carcinoma: Functionally and mechanistically, CASC11 drove HCC progression by recruiting EIF4A3 to regulate E2F1 affecting HCC cells proliferation, cell mobility, apoptosis, and cellular metabolism in vitro and in vivo.